Arcutis Biotherapeutics
Jan 07, 2020
Nunaps raises USD 4.2M; Arcutis files for USD 100M IPO
A South Korean startup therapeutics company Nunaps has successfully raised USD 4.2 Million around 5 billion won in a Series A round. The investment was made by the K Partners, KTB Network, and K2 Investment Partners. Nunaps is digital therapeutics and is planning to use the funds to build its digital thera...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
